Genetic deficiency or the inhibition of type 2-neutral sphingomyelinase (nSMase2), a key enzyme in sphingolipid metabolism, has been shown to decrease atherosclerosis in ApoE knockout mice by reducing inflammatory responses due to a decrease in ceramide levels [12]. This evidence concerns the gene APOE and atherosclerosis.